V2187
antibody from NSJ Bioreagents
Targeting: EPCAM
17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1
Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Immunohistochemistry [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2187 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- EpCAM Antibody
- Antibody type
- Monoclonal
- Antigen
- MCF-7 human breast cancer cells were used as the immunogen for this EpCAM antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- 323/A3
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the EpCAM antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form.
Functional consequences of EpCam mutation in mice and men.
The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancer.
Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry.
Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer.
Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors.
Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Salomon J, Goulet O, Canioni D, Brousse N, Lemale J, Tounian P, Coulomb A, Marinier E, Hugot JP, Ruemmele F, Dufier JL, Roche O, Bodemer C, Colomb V, Talbotec C, Lacaille F, Campeotto F, Cerf-Bensussan N, Janecke AR, Mueller T, Koletzko S, Bonnefont JP, Lyonnet S, Munnich A, Poirier F, Smahi A
Human genetics 2014 Mar;133(3):299-310
Human genetics 2014 Mar;133(3):299-310
Functional consequences of EpCam mutation in mice and men.
Mueller JL, McGeough MD, Peña CA, Sivagnanam M
American journal of physiology. Gastrointestinal and liver physiology 2014 Feb 15;306(4):G278-88
American journal of physiology. Gastrointestinal and liver physiology 2014 Feb 15;306(4):G278-88
The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancer.
Shigdar S, Qian C, Lv L, Pu C, Li Y, Li L, Marappan M, Lin J, Wang L, Duan W
PloS one 2013;8(2):e57613
PloS one 2013;8(2):e57613
Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry.
Takao M, Takeda K
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2011 Feb;79(2):107-17
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2011 Feb;79(2):107-17
Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer.
Ruf P, Gires O, Jäger M, Fellinger K, Atz J, Lindhofer H
British journal of cancer 2007 Aug 6;97(3):315-21
British journal of cancer 2007 Aug 6;97(3):315-21
Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors.
Heideman DA, Snijders PJ, Craanen ME, Bloemena E, Meijer CJ, Meuwissen SG, van Beusechem VW, Pinedo HM, Curiel DT, Haisma HJ, Gerritsen WR
Cancer gene therapy 2001 May;8(5):342-51
Cancer gene therapy 2001 May;8(5):342-51
Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Poczatek RB, Myers RB, Manne U, Oelschlager DK, Weiss HL, Bostwick DG, Grizzle WE
The Journal of urology 1999 Oct;162(4):1462-6
The Journal of urology 1999 Oct;162(4):1462-6
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of FFPE human colon carcinoma with EpCAM antibody.
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- Immunofluorescent testing of FFPE HT29 cells with EpCAM antibody (clone 323/A3). Green = EpCAM, red = F-actin and blue = DAPI (nuclear).